Age-dependent expression of osteochondrosis-related genes in equine leukocytes by Mendoza García, Luis et al.
Age-dependent expression of
osteochondrosis-related genes in equine
leukocytes
L. Mendoza,1,2 D. Piquemal,3,4,5 J. P. Lejeune,2 L. Vander Heyden,2 F. Noguier,5
R. Bruno,5 C. Sandersen,1 D. Serteyn1,2
To cite: Mendoza L, et al.
Age-dependent expression of
osteochondrosis-related
genes in equine leukocytes.
Vet Rec Open 2015;2:
e000058. doi:10.1136/
vetreco-2014-000058
▸ Prepublication history for
this paper are available
online. To view these files
please visit the journal online
(http://dx.doi.org/10.1136/
vetreco-2014-000058).
Received 3 June 2014
Revised 25 November 2014
Accepted 16 December 2014
This final article is available











Introduction: Osteochondrosis (OC) is a developmental
disease in horses which has a significant impact on
the horse’s welfare and performance. The early
disturbance in the process of endochondral ossification
progresses to inflammatory and repair processes in
older horses. Previously, differentially expressed genes
in leukocytes of OC-affected horses have been
identified. The aim of the present study is to detect
age-related changes in these differentially expressed
genes.
Materials and Methods: The expression of OC-related
genes was analysed by real-time PCR and subsequent
statistical analysis (ΔΔCT) in the leukocytes of 135
Belgian Warmblood horses divided into three different
age groups: <12 months (n=47), 18–24 months (n=50)
>30 months (n=38).
Results: Relative expression of genes of horses less
than 12 months of age showed significant induction of
the genes MGAT4A, PRKCG, MHCI, ApoB, ApoB3G,
B4GALT6 and a significantly lower expression of the
genes OAS3. Horses of 18–24 months of age, showed
a significantly higher expression of the genes TBC1D9,
MGAT4A, IFIH1, MHCIIa and MMP1. Horses of more
than 30 months of age showed a significantly higher
expression of the genes MGAT4A, HP, SECTM1
compared with their age-matched control groups.
Conclusions: The study demonstrates that OC-related
genes are differentially expressed in horses of different
ages compared with their age-matched controls. Some
of the genes may be implicated in cell signalling and
differentiation as well as carbohydrate and lipid
metabolism and inflammation. However, the causal
relationship between the differentially expressed genes
and the development and progression of the OC
lesions needs to be determined.
INTRODUCTION
Osteochondrosis (OC) is a developmental
disease of growing horses. It is deﬁned as a
disturbance in the process of endochondral
ossiﬁcation (Rejnö and Strömberg 1978).
The disturbance can lead to the formation of
detached fragments (osteochondrosis disse-
cans (OCD)), ﬁssures, or subchondral bone
cysts at the epiphyseal growth cartilage
(Rejnö and Strömberg 1978, Ytrehus and
others 2007). OCD is a frequent cause of
pain, lameness and reduced performance in
young athletic horses (McIlwraith 1993,
Verwilghen and others 2013).
The disease appears to be multifactorial in
origin, including skeletal growth rates, nutri-
tion, endocrinological factors, exercise, bio-
mechanics and genetic effects (Jeffcott
1991). Several studies have demonstrated dif-
ferentially expressed genes like, for example,
Indian hedgehog (Ihh), transforming growth
factor β 1 (TGF-β 1), Gli1 and insulin-like
growth factor I (IGF-I) parathyroid hormone-
related peptide (PTH-rP) in the cartilage of
OC-affected horses (Semevolos and others
2001, 2002, 2005, Zabek and others 2002).
In a previous study, we analysed the tran-
script proﬁle of leukocytes from horses
affected with OC using a high throughput
sequencing method (Serteyn and others
2010). Metabolic pathway analysis showed an
obvious dysregulation of several signalling
pathways related to cartilage formation and
cartilage repair, such as Wnt, Indian hedgehog
and TGF-β signalling pathways. Other genes
that were differentially regulated may play a
role in high-carbohydrate diet, abnormal
insulin metabolism or inﬂammation (Serteyn
and others 2010). Horses of this study had a
mean age of 2.5 years and were relatively old
regarding the origin of the disease. OC occurs
early in the age of the horse (Lecocq and
others 2008). The lesions undergo a variety of
processes until they become visible as radio-
graphic ﬁnding. Thereafter they may become
modiﬁed by regenerative or degenerative pro-
cesses (Jacket and others 2013). The global
aim of our research is to ﬁnd biomarkers of
samples which can be easily obtained. The suit-
ability of leukocytes for gene proﬁling is
related to their active metabolism and accessi-
bility by simple venipuncture (Liew and others
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2006). The aim of the present study is to investigate the
leukocyte gene expression of horses of different age
groups with OC lesions.
MATERIALS AND METHODS
One hundred and thirty-ﬁve Belgian Warmblood horses
were selected for this study, which followed a ‘case
control study’ model. Selection was made on the base of
the undoubtable results of the radiographies among the
horses presented at the European Centre of the horse
(Vielsalm, Belgium) by the breeders in the context of an
orthopaedic diseases screening programme. OC-affected
horses were classiﬁed into three different age groups:
<12 months (AGE 1, n=35), 18–24 months (AGE 2,
n=38), >30 months (AGE 3, n=26). Furthermore, 36
horses (AGE 1: n=12, AGE 2: n=12, AGE 3: n=12)
without any evidence of OC lesions were selected and
analysed as control groups.
All horses were sedated for the radiographic examin-
ation using detomidine (0.01 mg/kg intravenously)
alone or combined with butorphanol (0.02 mg/kg intra-
venously). The following views were taken: lateromedial
views of the four fetlocks, lateromedial and
plantarolateral-dorsomedial oblique views of the hocks
and a lateromedial view of the stiﬂes. Horses were diag-
nosed on the basis of characteristic lesions of abnormal
endochondral ossiﬁcation located in the metacarpo and
metarso phalangeal tibiotarsal, and femoro-patellar
joints (Denoix and others 2013). Concerning the fetlock
joint, fragmentation and irregularity observed on the
dorsal aspect of the sagittal ridge and the condyles of
the metacarpus or metatarsus were considered as OC
lesions. Horses with dorsal, palmar or plantar fragmenta-
tions at the margin of the proximal phalanx were not
included in this study. Concerning the hock, OC lesions
were identiﬁed as fragments still in place (intermediate
ridge) or surface irregularities of the trochlear ridge(s)
or malleolus. Concerning the stiﬂe joint, variably sized
irregularity or ﬂattening of the lateral trochlear ridge of
the femur with sometimes partial calciﬁcation of the
tissue within the defect were considered as OC lesions.
Horses with osteoarthritis and other radiological
abnormalities, which were not clearly OC lesions, were
excluded from this study. Blood was collected from each
horse with PAXgene blood RNA tubes (BD Diagnostics,
Le Pont de Claix, France) and frozen at −80°C for later
analysis.
Total RNA was extracted from whole blood (2.5 ml)
using the PAXgene blood RNA kit (Qiagen,
Courtaboeuf, France). The integrity of total RNA
extracted using the PAXgene method was checked by
capillary electrophoresis analysis on Agilent BioAnalyser
2100 (Agilent, Palo Alto, California, USA). RNA quantity
was measured using a spectrophotometer NanoDrop
ND-1000 (Thermo Scientiﬁc, Les Ulis, France).
cDNA was synthesised using ∼300 ng of total RNA and
performed, using the VILO reverse transcription Kit,
according to the manufacturer’s protocol (Invitrogen,
Cergy Pontoise, France).
Pre-ampliﬁcation was performed with a 22 pooled
(ﬁnal 0.2× of each) SYBR Green assay. After pre-
ampliﬁcation PCR, the product was treated with 4 U of
Exonuclease I (NEB) then diluted 1:5 with 1× TE Buffer
and stored in −80°C until needed. Quantitative PCR was
carried out using the 96.96 dynamic array (Fluidigm
Corporation, California, USA) following the manufac-
turer’s protocol. Speciﬁcally, a 5 μl sample mixture was
prepared for each sample containing 1× TaqMan Gene
Expression Master Mix, 1× GE Sample Loading Reagent
(Fluidigm PN 85000746), 1× EvaGreen (Interchim) and
each of diluted pre-ampliﬁed cDNA. 5 μl of Assay mix
was prepared with 1× each of SYBR Green assay and 1×
Assay Loading Reagent (Fluidigm PN 85000736). An
IFC controller was used to prime the ﬂuidics array
(chip) with control line ﬂuid and then with samples and
assay mixes in the appropriate inlets. After loading, the
chip was placed in the BioMark Instrument for a ﬁrst
step of thermal mixing at 50°C for two minutes, 70°C
for 30 minutes and 25°C for 10 minutes, then UNG &
HotStart step at 50°C for two minutes followed by 95°C
for two minutes. PCR was performed by 35 cycles at 95°
C for 15 seconds and 60°C for one minute. Finally,
melting curve was performed by increasing temperature
from 60 to 95°C. The data were analysed with Real-Time
PCR Analysis Software in the BIOMARK instrument
(Fluidigm Corporation, California, USA).
RNA level quantiﬁcation was assessed by calculating
2−ΔΔCT (Schmittgen and Livak 2008).
In the previous study, we identiﬁed 2553 genes signiﬁ-
cantly upregulated or downregulated between the OC
group and the control group (Serteyn and others 2010).
For this study, we have chosen 34 genes following differ-
ent criteria: a low P value (inferior to 0.1 per cent), fold
induction superior to 5, quality of annotation (existence
of a lot of predicted mRNA in the horse genome), and
a mix of upregulated and downregulated genes member-
ship of a known signalling pathway (Table 1). Four
control genes: WARS (tryptophanyl-tRNA synthetase),
RIGE (retinoic acid induced gene E protein), B2M (β-2
microglobulin) and TUBB2C (tubulin, β 2C), referred
to as housekeeping genes, were used to normalise
mRNA levels between different samples. These four
control genes were deﬁned in a previous transcriptomic
study (Serteyn and others 2010).
Statistical analysis was performed according to Yuan
and others (2008) using the data of control groups as
references values (ΔΔCT) respectively for each AGE.
Then, the signiﬁcance analysis of microarrays (SAM)
method was used to compare the levels of gene expres-
sion as a marker of OC, taking into account the age
effect between control samples and study samples. We
used the corrected P value based on the false discovery
rate (FDR) method (Tusher and others 2001). The
results are expressed for each gene as a ratio between
the expression levels in the OC-affected group versus the
2 Mendoza L, et al. Vet Rec Open 2015;2:e000058. doi:10.1136/vetreco-2014-000058
Open Access
group.bmj.com on April 27, 2015 - Published by http://vetrecordopen.bmj.com/Downloaded from 
healthy horses. Our statistical criterion for the SAM ana-
lysis was the following: only the genes with a level of
expression strictly below 0.7 or superior to 1.5 and satis-
fying at least a FDR strictly lower than 5 per cent were
considered as possible biomarkers.
RESULTS
The results of the SAM analysis were reported in Table 2
for each age group. We found several biomarkers satisfy-
ing our biomarker selection criterion.
Relative expression of genes of horses less than
12 months of age showed signiﬁcant induction of the
genes MGAT4A (mannosyl-glycol-protein acetylglucosa-
minyltransferase), PRKCG (protein kinase C, gamma),
MHCI (MHC class I, α chain), ApoB (apolipoprotein B),
ApoB3G (similar to apolipoprotein B mRNA editing
enzyme catalytic polypeptide-like 3G), B4GALT6
(β-1,4-galactosyltransferase 6), the three latter genes
were above the golden threshold of two-fold change.
Further, there was a signiﬁcantly lower expression of the
gene OAS3 (2050-oligoadenylate synthetase 3) with a
two-fold change.
Horses of 18–24 months of age, showed a signiﬁcantly
higher expression of the genes TBC1D9 (TBC1 domain
family, member 9 (with GRAM domain)), MGAT4A,
IFIH1 (interferon-induced helicase C domain-
containing protein 1), MHCIIa (similar to MHC class I,
α chain) and MMP1 (interstitial collagenase precursor),
withIFIH1 and MMP1 above the two-fold change for
upregulated genes.
Horses of more than 30 months of age showed a sig-
niﬁcantly higher expression of the genes MGAT4A, HP
(haptoglobin), SECTM1 (secreted and transmembrane
protein 1 precursor (protein K12)), MHCIIa, PYGL
(phosphorylase, glycogen, liver), CUL5 (cullin-5,
TABLE 1: List of the 33 genes selected on several criteria from Serteyn et al. (2010): a low P value (inferior to 0.1 per cent),





ADAMTLS4 ADAMTS-like protein 4 precursor ENSECAT00000020422
ApoB Apolipoprotein B ENST00000233242
ApoB3G similar to ApoB mRNA editing enzyme catalytic polypeptide-like 3G XM_001916520
B4GALT6 β-1,4-galactosyltransferase 6 ENSECAT00000018745
BMP5 Bone morphogenetic protein 5 ENSECAG00000007138
CLK1 Dual specificity protein kinase ENSECAT00000016444
CRKL Crk-like protein ENSECAT00000018670
CSNK1E Casein kinase I isoform epsilon ENSECAT00000023450
CtBP1 C-terminal-binding protein 1 ENSECAT00000016987
CUL5 Cullin-5 (vasopressin-activated calcium-mobilising receptor) ENSECAT00000026414
DVL1 Segment polarity protein dishevelled homologue DVL-1 ENST00000378891
DVL3 Segment polarity protein dishevelled homologue DVL-3 ENSECAT00000009739
FOXL1 Forkhead box L1 ENST00000320241
FOXO1 Forkhead box O1 ENST00000379561
FZD1 Frizzled family receptor 1 ENSECAG00000001326
GRB2 Growth factor receptor-bound protein 2 ENSECAG00000006524
GSK3B Glycogen synthase kinase 3 β ENSECAT00000026913
Hp Haptoglobin XM_001497810
IFIH1 Interferon induced with helicase C domain ENST00000263642
IKBKB Inhibitor of nuclear factor κ-B kinase subunit β ENSECAT00000005219
ISG15 Interferon-induced protein precursor ENSECAT00000001183
MGAT4A Mannosyl glycoproteinacetylglucosaminyltransferase ENSECAG00000015468
MHCI MHC class I heavy chain ENSECAT00000021999
MHCIIa Similar to MHC class II antigen DQ α chain ENSECAT00000022398
MMP1 Interstitial collagenase precursor (Matrix metalloproteinase-1) ENSECAT00000025715
OAS3 20-50-oligoadenylate synthetase 3 ENST00000549918
PPP1CB Protein phosphatase 1, catalytic subunit, β isoform ENSECAG00000009359
PPR2A Protein phosphatase 2, regulatory subunit A, α isoform ENSECAT00000019754
PRKCG Protein kinase C, γ ENSECAT00000020980
PYGL Phosphorylase, glycogen, liver ENSECAT00000013037
RUSC2 Iporin (interacting protein of Rab1) (RUN and SH3 domain-containing protein 2) ENSECAT00000026463
SECTM1 Secreted and transmembrane protein 1 precursor ENSECAT00000006039
SMAD5 SMAD family member 5 ENSECAG00000000815
TBC1D9 TBC1 domain family member 9B ENSECAT00000018936
WASH1 WAS protein family homologue 1 XM_001493185.2
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vasopressin-activated calcium mobilising receptor),
GSK3B (glycogen synthase kinase 3 β) and MMP1.
Again we found MMP1 above the golden two-fold
change threshold. Two other genes are worth mention-
ing: SECTM1 and HP. For the downregulated genes a
signiﬁcant lower expression of OAS3 and WASH1 (WAS
protein family homologue 1) were found by the SAM
analysis.
Based on our very low FDR rates we computed Fig 1
which combines in a Venn diagram the common
markers between the groups. We found several common
markers such as MGAT4A which is upregulated at all
ages and could be seen as our ‘supermarker’, OAS3 as a
common disease marker for groups of horses less than
12 months of age and horses of more than 30 months of
age, and two common markers MHCIIa and MMP1 for
horses of 18–24 months of age and horses of more than
30 months of age.
DISCUSSION
We previously demonstrated that leukocytes of affected
horses showed differential expression of genes related to
several metabolic pathways, for example, Wnt signalling,
insulin signalling, TGF-β signalling and Ihh signalling
(Serteyn and others 2010). Mature leukocytes have been
shown to express a variety of mRNAs and they are able
to respond to external stimuli by rapid and complex
changes in gene expression (Bertrand and others 2004).
Likewise, Liew and others (2006) considered peripheral
blood leukocytes as a surrogate tissue to substitute for
traditional tissue specimens that are not easily accessible.
The suitability of leukocytes for gene proﬁling is related
to their active metabolism and accessibility by simple
venipuncture, which may allow a repeated time-series
analysis of changes in gene expression in response to
changing environmental or disease factors (Liew and
others 2006). In horses, Kamm and others (2013) used
a similar method to study the transcript proﬁle of leuko-
cytes from horses affected by osteoarthritis.
Histology studies (Laverty and Girard 2013) and
cartilage-derived transcriptome studies have demon-
strated timely changes in the initiation and the progres-
sion of the cartilage lesions. The initial step in the
pathogenesis is one or several of the following events:
formation of a fragile cartilage, failure of chondrocyte
differentiation, subchondral bone necrosis, and failure
of blood supply to the growth cartilage (Ytrehus and
others 2007, Olstad and others 2013). In the more
chronic stages of the disease, secondary degenerative
and regenerative processes overshadow the initial events
(Bertone and others 2005). The timely fashion of the
events is also reﬂected in the transcriptome changes of
leukocytes of OC-affected horses compared with age-
matched OC-free controls. However, the transcript level
of the MGAT4A gene remains signiﬁcantly higher in the
OC-affected horses of all ages. This gene is implicated in
the intracellular transport of glucose via the membrane
localisation of GLUT2 (Johswich and others 2014). The
MGAT4A transcript level is signiﬁcantly higher in white
blood cells of peripheral blood of human patients
affected by type 2 diabetes (T2D) (Lopez-Orduña and
others 2007). They suggest that high levels of glucose
and triglycerides could induce the high MGAT4A tran-
script levels, especially in subjects with a particular T2D
genetic background. A similar explanation could be pro-
posed for the OC-affected foals. In an animal model,
transient hyperglycaemia causes persistent epigenetic
changes and altered gene expression during subsequent
normoglycemia. This mechanism implicates a mitochon-
drial pathway with a high superoxide anion production
TABLE 2: SAM-plot results with the overexpressed an
underexpressed genes
<12 months 18–24 months >30 months
Ratio FDR Ratio FDR Ratio FDR






OAS3 0.428 0.0 0.648 0.0
TBC1D9 1.89 0.0
IFIH1 2.35 0.0
MHCIIa 1.532 0.0 1.607 3.2







The Ratio (<0.7 and >1.5) and the FDR (<5 per cent) are reported
with the overexpressed (bold) and underexpressed (italic) genes.
The FDR is a corrected p value (Tusher et al. 2001)
SAM, significance analysis of microarrays
FIG 1: Venn diagram showing the number of common
markers between the three age groups
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(El-Osta and others 2008). Recently, abnormal mito-
chondria and endoplasmic reticulum were observed in
the deep zone of OC cartilage (Desjardin and others
2014). The mitochondrial dysfunction could be partially
explained by the altered Wnt signalling pathway
observed in the OC-affected horses because this pathway
is known as a key regulator of mitochondrial function
(Serteyn and others 2010, Yoon and others 2010).
Other genes identiﬁed as possible biomarkers in this
study are related to the carbohydrate and lipid metabol-
ism (APOB, TBC1D9, B4GALT6, PYGL, GSK3) or gene
expression, cell growth, apoptosis and differentiation
(APOB3G, PRKCG, CUL5, SECTM1, WASH1) or related
to inﬂammatory and immune mechanisms (OAS3,
MMP1, HP, IF1H1, MHCI, MHCIIa).
Their role in the pathogenesis of equine OC remains
to be determined, but a high-energy diet is known to
induce OC lesions in foals (Savage and others 1993,
Mirams and others 2009). These observations were illu-
strated recently by Vander Heyden and others (2013). It
appears that mares fed with concentrates during gesta-
tion are more likely to produce foals that are subse-
quently affected by OC compared with other mares.
Even though the real-time PCR analysis of the 135
horses is conclusive, the potential markers should be
subjected to individual analysis in order to validate their
clinical potential. Limitations of this study include the
fact that neither the affected joint nor other lesions of
endochondral ossiﬁcation such as subchondral cysts
have been considered.
Even if the causal relationship between the differen-
tially expressed genes and the development and progres-
sion of the OC lesions needs to be determined, this
study clearly demonstrates that OC-affected horses show
particular changes in their leukocyte transcriptome and
that these modiﬁcations change with age.
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